Beyond Silicon Valley: How AdviNOW Medical Built a Strategic Investment Network in Healthcare

Conventional startup wisdom says to raise from top-tier VCs. But what if the best investors aren’t venture capitalists at all?

In a recent episode of Category Visionaries, AdviNOW Medical founder James Bates revealed how breaking from Silicon Valley conventions helped him build strategic advantages in healthcare. The story begins with his own capital commitment – nearly $10 million invested personally into the company.

Skin in the Game

This substantial personal investment wasn’t just about funding – it was about signaling commitment to other investors and stakeholders. As James explains, “They know that I’m not skin deep, I’m like bone deep, if you will. My elbow is all the way deep inside… I’m all in to make AdviNOW successful.”

But more importantly, this personal investment gave him the freedom to pursue a different kind of funding strategy. Rather than chasing traditional VC money, AdviNOW sought out strategic investors who could accelerate their market entry.

Building Strategic Value Through Investment

“My lead investor for the last couple of rounds is a venture capital company called Accelerant Ventures,” James shared. But the real innovation came in their approach to strategic investors. “I also have companies like Global Med, which is a strategic investor. They sell medical equipment, and bundling AdviNOW software with their medical equipment is a strategy that they were considering.”

This approach turned investors into business partners, creating natural distribution channels and market validation. Each investment became more than just capital – it became a strategic partnership that could help AdviNOW navigate the complex healthcare landscape.

The Power of Ownership

This funding strategy had another advantage: maintaining significant ownership. As James notes, “If I funded AdviNOW purely from the external space, I would own a lot less of the company than I do now, that’s for sure.” This greater ownership stake gives him more control over the company’s strategic direction and more ability to make long-term decisions.

Building Industry Credibility

The strategic investor approach also helped solve one of the biggest challenges for healthcare startups: credibility. By partnering with established healthcare companies through investment, AdviNOW gained instant legitimacy in a notoriously conservative industry.

This was particularly important given their ambitious vision. “AdviNOW inevitably becomes a Google of healthcare,” James explains. Such a bold vision requires more than just capital – it requires strategic partnerships that can help navigate regulatory challenges and open doors to major healthcare institutions.

Looking to the Future

The strategic investment network continues to shape AdviNOW’s future opportunities. “I look forward to potentially partnering with one of those guys, maybe be acquired or competing to the better end. So we’ll see how that all plays out,” James shares.

For deep tech founders, particularly those entering regulated industries, AdviNOW’s funding strategy offers valuable lessons. Sometimes the best capital isn’t the most expensive or prestigious – it’s the capital that comes with strategic advantages that can accelerate your path to market.

The next time a Silicon Valley VC asks about your cap table, remember: in complex industries, the most valuable investors might be the ones who understand your market better than your technology.